In this review
A daily format should fit the day you actually have
GetRelief Rx offers compounded semaglutide and tirzepatide as sublingual suspensions, with the clinician determining the prescription and instructions. Raeliva’s dissolving tablets offer a different non-injection format, so compare the clinician’s instructions and the ongoing cost for the exact preparation. I would decide whether the proposed treatment and follow-up are workable before making convenience the reason to choose a long subscription. [1] [2]
The product description includes ongoing support, and the wider programme offers wellness resources and help coordinating clinician communication. These can be useful when food, activity and treatment need to fit around work. They do not establish a private dietitian appointment or a particular frequency of human contact. Clarify which support would help with the real problem you want to solve. [5] [6]
The lower monthly label belongs to a longer term
Semaglutide’s two-month starting offer is $209 per month, $418 total; its six-month label is $189 per month, $1,134 total. Tirzepatide starts at $359 per month and $718 total for two months, or $319 per month and $1,914 for six. The cost planner can put the two- and six-month offers on the same timeline. The site qualifies the prices by dose. Those totals are more useful than the smallest monthly number alone, but the selected prescription can still change the bill. [1] [2]
The general policy describes thirty-day recurring orders. Before choosing a two- or six-month plan, confirm what is charged now, when later payments occur and how the longer commitment works if care changes. The product page’s single-bottle feature does not tell a household the full term’s actual medication quantity or shipment schedule. Get those details with the selected invoice. [1] [2] [4]
Find out which payment is cancelled if treatment is declined
The process page says payment is collected before provider review and cancelled if no prescription is given. The terms separately say consultation fees cover the evaluation regardless of the outcome. That makes the itemized receipt important. I would want the order amount and any professional fee separated before treating the service as a no-cost way to try obtaining a prescription. [3] [7]
Services are described as generally cash-pay. Confirm any necessary testing and follow-up costs alongside the advertised medication and shipping. Neither payment nor a completed assessment guarantees a prescription, eligibility in a particular state or a personal result. A useful care package should make its responsibilities understandable even when the clinician recommends a different next step. [1] [2] [3] [8]
Stopping the next order can require action before renewal
The refund policy says refills may be processed or shipped up to seven days before the next thirty-day cycle. A cancellation before the displayed renewal date may therefore be too late to stop an order already being prepared. If processing, compounding or shipping has begun, the cancellation generally applies to later cycles. That distinction belongs in the budget before choosing the longer offer. [4]
Before processing, an eligible order cancellation can receive a full order-amount refund. That is different from a refund of every medical fee or an automatic reversal after treatment changes. Confirm both the cancellation and the actual order state. The policy’s early-processing description does not create a guaranteed seven-day cancellation buffer for every plan. [3] [4]
Treat the progress story as a story, not a deadline
The support hub describes phases of progress and displays selected patient experiences. Those examples may make the programme easier to picture, but they do not tell you when this particular preparation will produce a result. A slower response is a clinical review question, not proof that staying subscribed will necessarily unlock the next advertised phase. [6]
Compounded medicines are not FDA-approved. A branded-drug study cannot establish the same outcome for an under-the-tongue preparation simply because an ingredient name matches. The daily format should be evaluated on its own evidence, actual formulation and the clinician’s reason for proposing it. [1] [2] [9]
Know the practical remedy for a delivery problem
The policy asks customers to report an incorrect, damaged or defective product within seven days of delivery. A confirmed problem may lead to replacement or another corrective action. A missing order fourteen days beyond its expected date triggers a support investigation, not a promise that every parcel arrives within fourteen days. Keep the order and delivery details so the issue can be assessed. [4]
I would shortlist the service when the treatment discussion is appropriate, the everyday routine works and the full commitment is clear. Compare a dietitian service if the missing help is recurring nutrition care, or another prescribing programme if medication access is the main obstacle. Buy the support you can use and the care the clinician recommends, rather than the longest plan the monthly label makes attractive.
Understanding the cost
Published starting term totals: semaglutide $418/two months or $1,134/six months; tirzepatide $718/two or $1,914/six. Prices depend on dosing. Confirm initial payment, clinical fees and renewals rather than infer them from a monthly-equivalent label. [1] [2] [3] [4]
Build your cost estimateSources
- GetReliefRX: semaglutide sublingual product and term totals
- GetReliefRX: tirzepatide sublingual product and term totals
- GetReliefRX: December 2, 2024 terms and clinical/payment roles
- GetReliefRX: March 9, 2026 refund and subscription policy
- GetReliefRX: subscription programme and inclusions
- GetReliefRX: wellness resources and promotional framework
- GetReliefRX: assessment, payment and clinical-review process
- GetReliefRX: March 9, 2026 telehealth policy
- FDA: understanding compounded-drug risks
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.